Key Financial Data Of Reporting Company

BrightPath Biotherapeutics Co., Ltd. - Filing #7728430

Concept 2017-04-01 to
2017-12-31
As at
2017-12-31
2017-10-01 to
2017-12-31
2016-04-01 to
2017-03-31
As at
2017-03-31
2016-10-01 to
2016-12-31
2016-04-01 to
2016-12-31
As at
2016-12-31
Key financial data of reporting company
Business results of reporting company
Net sales
246,634,000 JPY
529,612,000 JPY
431,430,000 JPY
Ordinary profit (loss)
-1,172,418,000 JPY
-1,116,556,000 JPY
-711,892,000 JPY
Net assets
4,231,955,000 JPY
5,201,149,000 JPY
4,308,033,000 JPY
Total assets
4,471,402,000 JPY
5,408,300,000 JPY
4,501,469,000 JPY
Basic earnings (loss) per share
-31.52
-13.06
-32.74
-6.88
-21.45
Diluted earnings per share
Equity-to-asset ratio
0.934 xbrli:pure
0.958 xbrli:pure
0.949 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.